Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 5 |
| 1.1 List of Tables | 6 | 1 |
| 1.2 List of Figures | 6 | 1 |
| 2 Introduction | 6 | 3 |
| 2.1 What Is This Report About? | 7 | 1 |
| 2.2 Computed Tomography (CT) Systems Market Segmentation | 7 | 1 |
| 2.3 Definitions of Markets Covered in the Report | 8 | 1 |
| 3 Computed Tomography (CT) Systems Market, United States | 9 | 13 |
| 3.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2008-2015 | 9 | 2 |
| 3.2 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2015-2022 | 11 | 2 |
| 3.3 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2008-2015 | 13 | 2 |
| 3.4 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2015-2022 | 15 | 2 |
| 3.5 Computed Tomography (CT) Systems Market, United States, Average Price ($), 2008-2022 | 17 | 2 |
| 3.6 Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), 2014-2015 | 19 | 1 |
| 3.7 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2015 | 20 | 2 |
| 4 Overview of Key Companies in United States, Computed Tomography (CT) Systems Market | 22 | 2 |
| 4.1 Siemens Limited | 22 | 1 |
| 4.1.1 Company Overview | 22 | 1 |
| 4.2 GE Healthcare Limited | 22 | 1 |
| 4.2.1 Company Overview | 22 | 1 |
| 4.3 Toshiba Medical Systems Corporation | 22 | 1 |
| 4.3.1 Company Overview | 22 | 1 |
| 4.4 Philips Healthcare | 23 | 1 |
| 4.4.1 Company Overview | 23 | 1 |
| 5 Computed Tomography (CT) Systems Market Pipeline Products | 24 | 1 |
| 6 Financial Deals Landscape | 25 | 5 |
| 6.1 Acquisition | 25 | 1 |
| 6.1.1 BioTelemetry Acquires VirtualScopics for up to USD15.5 Million | 25 | 2 |
| 6.2 Partnerships | 27 | 1 |
| 6.2.1 Imbio and GE Healthcare Enter into Partnership | 27 | 1 |
| 6.2.2 Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies | 28 | 1 |
| 6.3 Venture Financing | 29 | 1 |
| 6.3.1 Fresh Medical Labs Raises USD0.5 Million in Venture Financing | 29 | 1 |
| 7 Recent Developments | 30 | 92 |
| 7.1 Corporate Communications | 30 | 1 |
| 7.1.1 Oct 24, 2016: Analogic Announces Leadership Transition | 30 | 1 |
| 7.1.2 Sep 27, 2016: Camargo Pharmaceutical Services Adds to Medical Device Expertise | 31 | 1 |
| 7.1.3 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories | 31 | 1 |
| 7.1.4 Sep 08, 2016: iCAD Announces Management Transition | 32 | 1 |
| 7.1.5 Sep 06, 2016: GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohaler in COPD at ERS International Congress | 33 | 2 |
| 7.1.6 Sep 01, 2016: NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China | 35 | 1 |
| 7.1.7 Aug 31, 2016: Bruce Elder Named CEO of MedQuest | 36 | 1 |
| 7.1.8 Aug 10, 2016: Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts | 37 | 1 |
| 7.1.9 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions | 37 | 1 |
| 7.1.10 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market | 38 | 1 |
| 7.1.11 May 25, 2016: ProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member | 38 | 1 |
| 7.1.12 May 11, 2016: Regeneron and Sanofi Genzyme to Present Additional Data from Pivotal Phase 2b Dupilumab Study in Adults with Uncontrolled Persistent Asthma at the American Thoracic Society International Conference | 39 | 1 |
| 7.1.13 May 10, 2016: Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA | 40 | 2 |
| 7.1.14 Apr 21, 2016: RefleXion Medical Strengthens Management Team to Bring Biology-Guided Radiotherapy Into the Clinic | 42 | 1 |
| 7.1.15 Feb 25, 2016: Algobate Announces Positive Pre-Phase 3 Meeting With FDA for Naloxone PRT in Opioid Induced Constipation | 43 | 2 |
| 7.1.16 Feb 22, 2016: IMRIS, Deerfield Imaging Board of Directors Appoints Andrew M. Flanagan as Chief Executive Officer | 45 | 1 |
| 7.1.17 Feb 17, 2016: Alliance HealthCare Services Announces Rhonda Longmore-Grund to Assume Chief Financial Officer Role as Part of Planned Transition | 45 | 1 |
| 7.1.18 Feb 08, 2016: Timothy Damadian Named President and CEO of FONAR | 46 | 1 |
| 7.1.19 Jan 26, 2016: Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic s Board | 47 | 1 |
| 7.1.20 Jan 14, 2016: WellStar Announces New Leadership Roles | 48 | 1 |
| 7.1.21 Jan 11, 2016: Bellicum Pharmaceuticals Announces regulatory milestones and program updates on its CAR T product candidate BPX-401 | 49 | 1 |
| 7.1.22 Dec 09, 2015: Foundation Radiology Group Announces New Board Member | 50 | 1 |
| 7.1.23 Dec 09, 2015: iCAD Appoints Andrew Sassine to Board of Directors | 50 | 1 |
| 7.1.24 Nov 25, 2015: Vital Images Names Dr. Paul A. Markham as Vice President of Marketing | 51 | 1 |
| 7.2 Financial Announcements | 51 | 1 |
| 7.2.1 Oct 27, 2016: Stryker reports third quarter 2016 results | 51 | 1 |
| 7.2.2 Oct 27, 2016: Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance | 52 | 2 |
| 7.2.3 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results | 54 | 1 |
| 7.2.4 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend | 55 | 2 |
| 7.2.5 Sep 19, 2016: FONAR Announces Fiscal 2016 Year End Earnings | 57 | 1 |
| 7.2.6 Aug 17, 2016: Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results | 58 | 2 |
| 7.2.7 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results | 60 | 1 |
| 7.2.8 Aug 04, 2016: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2016 | 61 | 2 |
| 7.2.9 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results | 63 | 3 |
| 7.2.10 Jul 25, 2016: Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA | 66 | 2 |
| 7.2.11 Jul 25, 2016: VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate | 68 | 1 |
| 7.2.12 Jul 21, 2016: Stryker reports second quarter 2016 results | 69 | 1 |
| 7.2.13 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results | 70 | 2 |
| 7.2.14 Jun 01, 2016: Analogic Announces Results for the Third Quarter Ended April 30, 2016 and Declares Quarterly Cash Dividend | 72 | 1 |
| 7.2.15 May 10, 2016: FONAR Announces 3rd Quarter and Nine Months Financial Results for Fiscal 2016 | 73 | 2 |
| 7.2.16 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results | 75 | 1 |
| 7.2.17 May 05, 2016: Alliance HealthCare Services Reports Results for the First Quarter Ended March 31, 2016 | 76 | 2 |
| 7.2.18 May 03, 2016: ICAD Reports First Quarter 2016 Financial Results | 78 | 2 |
| 7.2.19 Mar 10, 2016: Alliance HealthCare Services Reports Fourth Quarter &Full Year 2015 Results | 80 | 2 |
| 7.2.20 Mar 02, 2016: Analogic Announces Results for the Second Quarter Ended January 31, 2016 and Declares Quarterly Cash Dividend | 82 | 2 |
| 7.2.21 Mar 01, 2016: iCAD Reports Fourth Quarter and Full Year 2015 Financial Results | 84 | 2 |
| 7.2.22 Feb 09, 2016: FONAR Announces Fiscal 2016 2nd Quarter and Six Months Financial Results | 86 | 1 |
| 7.2.23 Nov 18, 2015: Analogic Announces Preliminary First Quarter Results and Updates Its Fiscal 2016 Outlook | 87 | 1 |
| 7.2.24 Nov 09, 2015: FONAR Announces Fiscal 2016 1st Quarter Financial Results | 88 | 1 |
| 7.2.25 Nov 05, 2015: Alliance HealthCare Services Reports Third Quarter 2015 Results | 89 | 2 |
| 7.3 Government and Public Interest | 91 | 1 |
| 7.3.1 Jun 05, 2016: LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer | 91 | 2 |
| 7.3.2 May 23, 2016: Teijin Pharma s Feburic (Febuxostat) Approved as Indication for Cancer Chemotherapy-Induced Hyperuricemia | 93 | 1 |
| 7.3.3 May 22, 2016: Data from New Analyses of Studies with Veltassa Presented at 53rd European Renal Association Congress | 94 | 3 |
| 7.3.4 Apr 25, 2016: GlycoMimetics Data on GMI-1271 Treatment of Acetaminophen-Triggered Liver Toxicity to Be Presented at "Digestive Disease Week" Conference | 97 | 1 |
| 7.3.5 Apr 13, 2016: Bio Products Laboratory Announces FDA Submission of Biologics License Supplement for Gammaplex 10% | 98 | 1 |
| 7.3.6 Mar 01, 2016: Nordic Nanovector: Late-Breaking Abstract on Betalutin Phase 1/2 Study Accepted for Presentation at American Association for Cancer Research Annual Meeting 2016 | 99 | 1 |
| 7.3.7 Jan 28, 2016: European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV | 100 | 3 |
| 7.3.8 Dec 17, 2015: Preliminary 15-month results from DIABGAD a 30-month pilot study with the diabetes vaccine Diamyd in combination with vitamin D and ibuprofen | 103 | 4 |
| 7.4 Legal And Regulatory | 107 | 1 |
| 7.4.1 Aug 15, 2016: Med Center Health Facilities Earn ACR Lung Cancer Screening Center Designation | 107 | 1 |
| 7.5 Other Significant Developments | 108 | 1 |
| 7.5.1 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program | 108 | 1 |
| 7.5.2 Jun 21, 2016: iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography | 109 | 1 |
| 7.5.3 Jun 09, 2016: NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies | 109 | 1 |
| 7.5.4 Apr 01, 2016: BTG announces US launch of LC Bead LUMI, ground-breaking radiopaque embolic bead | 110 | 2 |
| 7.5.5 Mar 22, 2016: The University of Tennessee College of Medicine Launches the World s First Mobile Stroke Unit with Advanced CT Imaging Capabilities Including CT Angiography Imaging for the Brain and Blood Vessels | 112 | 1 |
| 7.5.6 Jan 05, 2016: University of Iowa Hospitals and Clinics Selects Local Startup, VIDA, for Precision Pulmonology Imaging Solution | 113 | 1 |
| 7.5.7 Dec 08, 2015: Analogic Announces Results for the First Quarter Ended October 31, 2015 and Declares Quarterly Cash Dividend | 114 | 1 |
| 7.6 Product News | 115 | 1 |
| 7.6.1 Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis | 115 | 1 |
| 7.6.2 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress | 116 | 1 |
| 7.6.3 Jun 08, 2016: NICE draft recommendation on the use of aflibercept (EYLEA) for management of branch retinal vein occlusion goes against Royal College of Ophthalmologists guidance | 117 | 1 |
| 7.6.4 Apr 26, 2016: Philips receives FDA 510(k) clearance of CT imaging solutions for lung cancer screening to help hospitals of all sizes drive earlier detection and improve patient care decisions | 118 | 1 |
| 7.6.5 Dec 17, 2015: Accuray Hosts First Regional Users Meeting | 119 | 1 |
| 7.7 Strategy And Business Planning | 120 | 1 |
| 7.7.1 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR | 120 | 2 |
| 8 Appendix | 122 | 7 |
| 8.1 Research Methodology | 123 | 5 |
| 8.1.1 Coverage | 123 | 1 |
| 8.1.2 Secondary Research | 123 | 1 |
| 8.1.3 Primary Research | 124 | 1 |
| 8.1.4 Market Modeling and Forecasting | 125 | 1 |
| 8.1.5 Company Share Analysis | 126 | 1 |
| 8.1.6 Distribution Share Analysis | 127 | 1 |
| 8.1.7 Benchmarking | 127 | 1 |
| 8.2 GlobalData Consulting | 127 | 1 |
| 8.3 Contact Us | 128 | 1 |
| 8.4 Disclaimer | 128 | 1 |
